Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients-Reference-Cited by-同舟云学术

Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Published:2016-04-28 Issue:7 Volume:4 Page:592-599
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Tada Kohei,Kitano Shigehisa,Shoji Hirokazu,Nishimura Takashi,Shimada Yasuhiro,Nagashima Kengo,Aoki Kazunori,Hiraoka Nobuyoshi,Honma Yoshitaka,Iwasa Satoru,Okita Natsuko,Takashima Atsuo,Kato Ken,Yamada Yasuhide,Katayama Naoyuki,Boku Narikazu,Heike Yuji,Hamaguchi Tetsuya

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer;OncoImmunology;2024-06-10

2. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study;British Journal of Cancer;2023-12-15

3. Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition;Journal for ImmunoTherapy of Cancer;2023-12

4. Exploiting innate immunity for cancer immunotherapy;Molecular Cancer;2023-11-27

5. Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis;Frontiers in Oncology;2023-09-26